发明名称 Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis
摘要 This invention relates to novel sulfone 2I3-dihydroimidazo[1 l2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis mediated disorders, as a sole agent or in combination with other active ingredients.
申请公布号 US8859572(B2) 申请公布日期 2014.10.14
申请号 US200912812911 申请日期 2009.01.13
申请人 Bayer Intellectual Property GmbH 发明人 Hentemann Martin F.;Scott William;Wood Jill;Johnson Jeffrey;Redman Aniko;Bullion Ann-Marie;Guernon Leatte
分类号 A61K31/519;A61K45/06;A61K31/541;C07D487/04 主分类号 A61K31/519
代理机构 代理人
主权项 1. A compound having the formula: or a physiologically acceptable salt thereof, wherein: R1 is a heteroaryl optionally substituted with 1, 2 or 3 R4 groups; R2 is hydrogen, alkoxy, heterocyclylalkyl, heterocyclylalkoxy or R3; each occurrence of R3 is independently—Y—SOq—Z or —Y—N(R5)—SOq—Z; each occurrence of X is independently —C(R5)— or —N—; each occurrence of Y is independently a bond, alkoxy, alkoxyalkoxy or arylalkoxy; each occurrence of Z is independently alkyl, —N(R6)(R6′), or -heterocyclylalkyl optionally substituted with 1, 2 or 3 R4 groups; each occurrence of R4 may be the same or different and is independently amino, halogen, amino, alkylamino, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalklyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl; each occurrence of R5 is independently hydrogen or alkyl; each occurrence of R6 and R6′ may be the same or different and is independently hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalklyl, cycloalkenyl, aryl, arylalkyl, heteroaryl, heterocyclyl, or heterocyclylalkyl, wherein R6 and R6′ may be attached to each other to form a heterocyclic ring through a bond or through one or more O, C, N, S, SOq or carbonyl, and wherein at least one N is part of the heterocyclic ring; and each occurrence of n is independently an integer from 1-4; and each occurrence of p is independently an integer from 0-2.
地址 Monheim DE